Investigational Site Number 578101

Oslo 0372

0 studies enrolling now · 1 studies all time

What they study most

Dyslipidemia

Studies at this site

• Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia) — Completed